LOURIA HAYON IGAL (Chief Technology Officer) reported 1 transaction at RAPHAEL PHARMACEUTICAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/6/2026ACC: 0001213900-26-040590
DirectorOfficer· Chief Technology Officer
Since Sep 2021
0.00
Net shares
Net seller
$3.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
350K acquired · 350K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+350K
Price / share
$0.01
Trade value
$3.50K
% of position
35.0%
11/20/2025
999K→1.35M
Total
Net shares
+350K
Net value
$3.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2025 | X · X | +350K | $0.01 | $3.50K | 35.0% | 999K | 1.35M |
| Total | +350K | $3.50K | ||||||
Derivative Transactions1
Warrants to purchase Common Stock
Direct
Converts to
Common Stock
350K shares
Shares
−350K
Strike price
0.01
Held after
0.00
Exercisable
—
11/20/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants to purchase Common Stock Direct | Common Stock350K shares | 11/20/2025 | X · X | −350K | 0.01 | — | 0.00 |